Literature DB >> 17301838

Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes.

Arup Kumar Indra1, Eduardo Castaneda, Maria Cristina Antal, Ming Jiang, Nadia Messaddeq, Xiangjun Meng, Christiane V Loehr, Patricio Gariglio, Shigeaki Kato, Walter Wahli, Béatrice Desvergne, Daniel Metzger, Pierre Chambon.   

Abstract

Retinoid-X-receptor alpha (RXRalpha), a member of the nuclear receptor (NR) superfamily, is a ligand-dependent transcriptional regulatory factor. It plays a crucial role in NR signalling through heterodimerization with some 15 NRs. We investigated the role of RXRalpha and its partners on mouse skin tumor formation and malignant progression upon topical DMBA/TPA treatment. In mutants selectively ablated for RXRalpha in keratinocytes, epidermal tumors increased in size and number, and frequently progressed to carcinomas. As keratinocyte-selective peroxisome proliferator-activated receptor gamma (PPARgamma) ablation had similar effects, RXRalpha/PPARgamma heterodimers most probably mediate epidermal tumor suppression. Keratinocyte-selective RXRalpha-null and vitamin-D-receptor null mice also exhibited more numerous dermal melanocytic growths (nevi) than control mice, but only nevi from RXRalpha mutant mice progressed to invasive human-melanoma-like tumors. Distinct RXRalpha-mediated molecular events appear therefore to be involved, in keratinocytes, in cell-autonomous suppression of epidermal tumorigenesis and malignant progression, and in non-cell-autonomous suppression of nevi formation and progression. Our study emphasizes the crucial role of keratinocytes in chemically induced epidermal and melanocytic tumorigenesis, and raises the possibility that they could play a similar role in UV-induced tumorigenesis, notably in nevi formation and progression to melanoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301838     DOI: 10.1038/sj.jid.5700672

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  42 in total

1.  The vitamin D receptor: a tumor suppressor in skin.

Authors:  Daniel David Bikle
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

Review 2.  Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Wojciech Jóźwicki; Anton M Jetten; Rebecca S Mason; Robert C Tuckey; Craig A Elmets
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

3.  Loss of nuclear receptor RXRα in epidermal keratinocytes promotes the formation of Cdk4-activated invasive melanomas.

Authors:  Stephen Hyter; Gaurav Bajaj; Xiaobo Liang; Mariano Barbacid; Gitali Ganguli-Indra; Arup Kumar Indra
Journal:  Pigment Cell Melanoma Res       Date:  2010-07-09       Impact factor: 4.693

Review 4.  Vitamin D and cancer: the promise not yet fulfilled.

Authors:  Daniel D Bikle
Journal:  Endocrine       Date:  2014-01-09       Impact factor: 3.633

Review 5.  Protective role of vitamin D signaling in skin cancer formation.

Authors:  Daniel D Bikle; Hashem Elalieh; Joellen Welsh; Dennis Oh; James Cleaver; Arnaud Teichert
Journal:  J Steroid Biochem Mol Biol       Date:  2012-10-08       Impact factor: 4.292

Review 6.  Photoprotective Properties of Vitamin D and Lumisterol Hydroxyderivatives.

Authors:  Andrzej T Slominski; Anyamanee Chaiprasongsuk; Zorica Janjetovic; Tae-Kang Kim; Joanna Stefan; Radomir M Slominski; Vidya Sagar Hanumanthu; Chander Raman; Shariq Qayyum; Yuwei Song; Yuhua Song; Uraiwan Panich; David K Crossman; Mohammad Athar; Michael F Holick; Anton M Jetten; Michal A Zmijewski; Jaroslaw Zmijewski; Robert C Tuckey
Journal:  Cell Biochem Biophys       Date:  2020-05-22       Impact factor: 2.194

7.  Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.

Authors:  Pit Sertznig; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

8.  Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment.

Authors:  Daniel J Coleman; Sharmeen Chagani; Stephen Hyter; Anna M Sherman; Christiane V Löhr; Xiaobo Liang; Gitali Ganguli-Indra; Arup K Indra
Journal:  Mol Cancer Res       Date:  2014-09-04       Impact factor: 5.852

9.  The peroxisome proliferator-activated receptor gamma system regulates ultraviolet B-induced prostaglandin e(2) production in human epidermal keratinocytes.

Authors:  Raymond L Konger; Kellie Clay Martel; Danielle Jernigan; Qiwei Zhang; Jeffrey B Travers
Journal:  PPAR Res       Date:  2010-05-19       Impact factor: 4.964

Review 10.  The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Zorica Janjetovic; Tae-Kang Kim; Radomir M Slominski; Robert C Tuckey; Rebecca S Mason; Anton M Jetten; Purushotham Guroji; Jörg Reichrath; Craig Elmets; Mohammad Athar
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.